ArticleRSC advances2026
Bimetallic ZIF nanoplatform for pH-responsive curcumin delivery: synthesis, characterization, and
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The exploration of zeolitic imidazolate framework (ZIF)-based nanoplatforms for drug delivery has attracted increasing attention in recent years. In this study, a bimetallic ZIF (BZIF) containing Zn and Co was synthesized through a simple one-pot approach under mild conditions. The formation of BZIF was confirmed through comprehensive physicochemical characterization. Curcumin (CUR) was subsequently loaded onto BZIF to obtain the CBZIF nanoplatform. CBZIF exhibited pH-responsive CUR release, with cumulative release reaching 78.19% at pH 5.5 compared with 44.25% at pH 7.4 after 72 h.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.